Resumen

BARRIGA-SALAVERRY, Guillermo. Tomographic biomarkers in diabetic macular edema. Rev Med Hered [online]. 2022, vol.33, n.1, pp.56-63.  Epub 31-Mar-2022. ISSN 1018-130X.  http://dx.doi.org/10.20453/rmh.v33i1.4170.

Diabetic macular edema (DME) is the leading cause of decreased vision among diabetic patients. It can begin in any of the stages of diabetic retinopathy and be associated with comorbidities that can affect various body systems. Many times, the diabetic patient with macular edema needs multidisciplinary management through which he receives initial care from non-ophthalmologist specialists. There is evidence to support that early diagnosis and prompt treatment of DME can minimize permanent visual loss. Non-ophthalmologist specialists who care for diabetic patients can help to detect the DME that their patient may have early to receive the corresponding ophthalmological care. The purpose of this review is to provide the medical community with information on the contribution of optical coherence tomography in the diagnosis of DME and how to recognize tomographic biomarkers that allow predicting the visual outcome of its treatment.

Palabras clave : Optical Coherence Tomography; diagnosis; treatment outcome; predictive value of tests; diabetic retinopathy; vision disorders.

        · resumen en Español     · texto en Español     · Español ( pdf )